
Cipher Pharmaceuticals Inc
TSX:CPH

Intrinsic Value
The intrinsic value of one
CPH
stock under the Base Case scenario is
9.92
CAD.
Compared to the current market price of 12.28 CAD,
Cipher Pharmaceuticals Inc
is
Overvalued by 19%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Cipher Pharmaceuticals Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Cipher Pharmaceuticals Inc
Balance Sheet Decomposition
Cipher Pharmaceuticals Inc
Current Assets | 40.1m |
Cash & Short-Term Investments | 22m |
Receivables | 11.8m |
Other Current Assets | 6.4m |
Non-Current Assets | 122.9m |
PP&E | 602k |
Intangibles | 94.5m |
Other Non-Current Assets | 27.9m |
Free Cash Flow Analysis
Cipher Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Cipher Pharmaceuticals Inc
Revenue
|
39.5m
USD
|
Cost of Revenue
|
-11.1m
USD
|
Gross Profit
|
28.4m
USD
|
Operating Expenses
|
-21.2m
USD
|
Operating Income
|
7.3m
USD
|
Other Expenses
|
2m
USD
|
Net Income
|
9.2m
USD
|
CPH Profitability Score
Profitability Due Diligence
Cipher Pharmaceuticals Inc's profitability score is 77/100. The higher the profitability score, the more profitable the company is.

Score
Cipher Pharmaceuticals Inc's profitability score is 77/100. The higher the profitability score, the more profitable the company is.
CPH Solvency Score
Solvency Due Diligence
Cipher Pharmaceuticals Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Score
Cipher Pharmaceuticals Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CPH Price Targets Summary
Cipher Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
CPH
is 16.34 CAD
with a low forecast of 13.13 CAD and a high forecast of 19.53 CAD.
Dividends
Current shareholder yield for CPH is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CPH
stock under the Base Case scenario is
9.92
CAD.
Compared to the current market price of 12.28 CAD,
Cipher Pharmaceuticals Inc
is
Overvalued by 19%.